BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Programmed cell death protein 1
1
Roles of the tumor microenvironment in the resistance to programmed cell death protein 1 inhibitors in patients with gastric cancer
9/9/2024 8:41:20 AM | Browse: 144 | Download: 553
2
Human epidermal growth factor receptor 2 expression level and combined positive score can evaluate efficacy of advanced gastric cancer
5/21/2024 7:25:52 AM | Browse: 106 | Download: 804
3
Hepatic arterial infusion chemotherapy with/without anti-angiogenesis agents and immune checkpoint inhibitors for unresectable hepatocellular carcinoma and meta-analysis
1/26/2024 7:56:29 AM | Browse: 335 | Download: 1276
4
Combined TIM-3 and PD-1 blockade restrains hepatocellular carcinoma development by facilitating CD4+ and CD8+ T cell-mediated antitumor immune responses
12/14/2023 5:08:46 AM | Browse: 191 | Download: 885
5
Immunotherapy in combination with chemotherapy for Peutz-Jeghers syndrome with advanced cervical cancer: A case report
3/27/2023 2:19:30 PM | Browse: 345 | Download: 900
6
Hypophysitis induced by anti-programmed cell death protein 1 immunotherapy in non-small cell lung cancer: Three case reports
10/21/2022 2:24:59 AM | Browse: 565 | Download: 1390
7
Tsunami of immunotherapy reaches mesothelioma
4/22/2022 8:49:02 AM | Browse: 597 | Download: 1459
8
Recurrent undifferentiated embryonal sarcoma of the liver in adult patient treated by Perbrolizumab: A case report
3/30/2021 8:56:50 AM | Browse: 589 | Download: 1890
9
Exploring the food-gut axis in immunotherapy response of cancer patients
9/4/2020 7:25:49 AM | Browse: 902 | Download: 2044
10
Immune checkpoint inhibitor-induced colitis: A comprehensive review
2/26/2019 9:05:11 AM | Browse: 992 | Download: 1912
Write to the Help Desk
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345